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Abstract A family of suppressors of cytokine signaling (SOCS)
has recently been identified of which two members have been
shown to block growth hormone (GH) signaling. Dose-response
experiments were conducted in 293 cells and SOCS-1 and
SOCS-3 were shown to inhibit the transcriptional activation of a
GH-responsive element and suppressed Jak2 tyrosine kinase
activity. SOCS-2 had two opposite effects: at low concentrations
it inhibited GH-induced STAT5-dependent gene transcription,
but restoration of GH signaling was observed at higher
concentrations. In cotransfection studies, SOCS-2 was able to
block the inhibitory effect of SOCS-1 but not that of SOCS-3 on
GH signaling. These findings suggest that a major function for
SOCS-2 is to restore the sensitivity to GH by overcoming the
initial inhibitory effects of other endogenous SOCS molecules.
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1. Introduction
Growth hormone (GH) is the major regulator of postnatal
body growth [1]. It exerts diverse and pleiotropic e¡ects on the
growth, di¡erentiation and metabolism of cells. GH initiates
its biological actions, including the regulation of expression of
a broad range of genes in mammalian tissues, by interacting
with a speci¢c membrane-bound receptor. GH receptor
(GHR) signaling involves ligand-induced receptor homodi-
merization and activation of the tyrosine kinase Jak2 [2,3].
These events initiate a cascade of phosphorylation of cellular
proteins including the kinase itself and the receptor, thereby
providing docking sites for src homology domain 2 (SH2)-
containing molecules such as the latent cytoplasmic signal
transducer and activator of transcription 5 (STAT5) [4].
Jak2 activation results in the phosphorylation, dimerization
and nuclear translocation of activated STAT factors which
bind to their DNA-responsive elements to activate gene tran-
scription.
The mechanism by which GH signaling is switched o¡ is
less known. Recent studies [5^13] have identi¢ed a novel fam-
ily of cytokine-inducible inhibitors of signaling (SOCS) which
includes eight members (SOCS-1, -2, -3, -4, -5, -6, -7 and CIS)
that act in a classical negative feedback loop to regulate cy-
tokine signal transduction. Transcription of the SOCS-1 gene
is induced in response to a variety of cytokines and the pro-
tein has been shown to interact with and to inhibit the tyro-
sine phosphorylation of the members of the Jak kinase family
as well as other tyrosine kinases. CIS, on the other hand,
appears to negatively regulate cytokine signaling by compet-
ing with STAT5 for tyrosine docking sites on the erythropoie-
tin and interleukin-3 (IL-3) receptors [5]. SOCS-1 and SOCS-3
have been shown to block IL-6, GH, prolactin (PRL) signal-
ing as well as interferon-mediated antiviral and antiprolifera-
tive activities [14^18], though with di¡erent regulatory roles
and di¡erent potencies. Although SOCS-3 also binds to the
Jak2 tyrosine kinase domain (JH1), it is not clear whether it
can inhibit its tyrosine kinase activity [14,17]. The regulatory
role of SOCS-2 is less de¢ned; it surprisingly appeared to
facilitate the superinduction of a reporter gene in response
to GH [15] and was shown to interact with the insulin-like
growth factor-I (IGF-1) receptor [19]. The present study was
conducted to clarify the e¡ect of SOCS-2 on GH signaling
and its interaction with other SOCS molecules.
2. Materials and methods
2.1. Hormone
Recombinant human GH was kindly provided by Serono-Ares
Laboratories (Geneva, Switzerland). Anti-Flag monoclonal antibody
M2 is a product of IBI-Kodak. The anti-phosphotyrosine antibody
and the anti-Jak2 antibody were purchased from Upstate Biotechnol-
ogy, Inc.
2.2. Cell culture and transfection
Human kidney ¢broblast 293 cells were grown in Dulbecco’s modi-
¢ed Eagle’s medium nut F12 medium (Gibco) containing 10% fetal
bovine serum. Several hours before transfection, cells were plated in
two-thirds Dulbecco’s modi¢ed Eagle’s medium nut F12, one-third
Dulbecco’s modi¢ed Eagle’s medium 4.5 g/l glucose medium contain-
ing 10% fetal bovine serum.
For GH-dependent induction of reporter construct, 293 cells were
plated in 6 well plates before being transiently cotransfected by the
calcium phosphate technique as previously described [20,21] with 100
ng of the L-galactosidase-encoding vector, 100 ng of the lactogenic
hormone responsive element (LHRE)-TK-luciferase reporter gene (fu-
sion gene carrying six copies of the LHRE and the thymidine kinase
(TK) minimal promoter linked to the coding region of the luciferase
gene (LHRE is a STAT5 binding element of the L-casein promoter),
50 ng of plasmid pcDNA3/monkey (mk) GHR [20] and increasing
concentrations (0^250 ng DNA) of Flag epitope-tagged SOCS-1,
SOCS-2, SOCS-3 or CIS, also referred to as CIS1, in pEF-BOS ex-
pression vector (kindly provided by Drs. D.J. Hilton and R. Starr).
One day after transfection, cells were incubated with serum-free me-
dium containing 50 nM hGH for 24 h. Cells were then lysed in lysis
bu¡er (Pharmacia) and whole cell extracts were used for determina-
tion of luciferase and L-galactosidase activities. Aliquots of lysates
were analyzed by Western blot using anti-Flag monoclonal antibody
M2 and con¢rmed that increasing the concentration of transfected
SOCS plasmids resulted in increased expression of SOCS proteins
(data not shown).
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2.3. Immunoprecipitation and Western blot analysis
Each 100 mm culture dish of 293 cells was cotransfected with 4 Wg
of GHR cDNA, 0.2 Wg of the cDNA encoding Jak2 (kindly provided
by Dr. J. Ihle) and 8 Wg of each form of SOCS-encoding plasmid. In
these conditions Jak2 is tyrosine phosphorylated and active in the
absence of GH stimulation in 293 cells because of its high level of
expression [7,14]. Cells were subsequently lysed as previously de-
scribed [22] and the lysates were incubated with anti-Jak2 antibody
(1 Wg/ml) and collected using protein A-agarose. Immunoprecipitated
proteins were separated by SDS-polyacrylamide gel electrophoresis
(7%), transferred onto polyvinylidene di£uoride transfer membrane
(Polyscreen, DuPont NEN) and immunodetected with appropriate
antibodies to Jak2 (UBI, 1/1000) and anti-phosphotyrosine (UBI,
1/10 000) and visualized by chemiluminescence (ECL kit from Amer-
sham).
3. Results
3.1. E¡ects of SOCS molecules on GH-induced transactivation
of transcription
GH can activate transcription of the chimeric LHRE re-
porter gene in the absence of constitutive expression of
SOCS genes in 293 cells. A maximal activation of 13.3 þ 0.7
(n = 7) times was obtained upon GH stimulation when SOCS
plasmids were not transfected. Luciferase activity obtained in
dose-response experiments was normalized to these maximal
fold induction values and is expressed as a percentage of these
values. Dose-response experiments with SOCS molecules were
conducted to analyze in detail the e¡ect of each SOCS. The
constitutive expression of the SOCS-1 (Fig. 1) or SOCS-3 gene
(Fig. 2) at increasing concentrations resulted in the total in-
hibition of the activation of transcriptional activity and this
inhibition was e¡ective starting with very low doses of trans-
fected cDNA (5 ng/well which represents a 1:0.1 ratio of
GHR to SOCS). Both SOCS molecules displayed similar po-
tency in inhibiting signaling. Surprisingly, expression of the
SOCS-2 gene at increasing concentrations resulted in two op-
posite e¡ects (Fig. 3); the ¢rst was a 50% inhibitory e¡ect that
was obtained with low doses of transfected cDNA in the
range of 5^25 ng/well (corresponding to a 1:0.1 to a 1:0.5
ratio of GHR to SOCS-2); however, a second e¡ect was ob-
tained with higher concentrations of transfected SOCS-2 plas-
mid and was characterized by a dose-related restoration of
transactivation of transcription reaching even a superinduc-
tion (200%) of the maximal activation obtained in the absence
of constitutive expression of SOCS genes (Fig. 3). As ex-
pected, constitutive expression of the CIS gene did not a¡ect
activation of gene transcription (data not shown).
Fig. 1. E¡ect of constitutive expression of SOCS-1 on induction of
the LHRE-luciferase reporter gene by hGH. 293 cells were trans-
fected and assayed as described in Section 2. Results of luciferase
activity were assayed in cells transfected with di¡erent ratios (1:0,
1:0.05, 1:0.1, 1:0.25, 1:0.5 to 1:5) of mkGHR to SOCS-1 cDNA.
The dose-response curve is expressed in percentage of control activ-
ity (in the absence of cotransfected SOCS-1). 100% corresponds to a
control luciferase induction of 13.3-fold. Values are the means
þ S.E.M. of four to seven independent experiments.
Fig. 2. E¡ect of constitutive expression of SOCS-3 on GH-induced
transactivation of LHRE-TK promoter. 293 cells were transfected
and assayed as described in Fig. 1. The same ratios of mkGHR to
SOCS-3 cDNA (1:0 to 1:5) as described in Fig. 1 were used. The
dose-response curve is expressed in percentage of control activity (in
the absence of cotransfected SOCS-3). Values are the means
þ S.E.M. of three to seven independent experiments.
Fig. 3. Dual e¡ect of constitutive expression of SOCS-2 on GH-in-
duced activation of LHRE-TK promoter. 293 cells were transfected
and assayed as described in Fig. 1. Di¡erent ratios (1:0, 1:0.02,
1:0.04, 1:0.1, 1:0.2, 1:0.5 to 1:5) of mkGHR to SOCS-2 cDNA
were used in transfection studies. The dose-response curve is ex-
pressed in percentage of control activity (in the absence of cotrans-
fected SOCS-2). Values are the mean þ S.E.M. of four to seven ex-
periments.
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3.2. E¡ects of co-expression of di¡erent SOCS molecules on
GH-dependent activation of gene transcription
To analyze the mechanism by which SOCS-2 was able to
restore activation at higher concentrations, experiments were
designed to analyze the interactions of SOCS molecules in GH
signaling, based on the hypothesis that SOCS-2 may inhibit
endogenous SOCS that are induced by GH and which are
required to inhibit GH signaling itself. As SOCS-1 and
SOCS-3 were shown to be potent inhibitors of GH-mediated
activation of gene transfection in the previous experiments,
their respective cDNAs encoding plasmids were cotransfected
together with that encoding SOCS-2 protein. As shown in Fig.
4, the constitutive expression of SOCS-1 and SOCS-2 at in-
creasing concentrations resulted, in a dose-dependent manner,
in the restoration of the transactivation of transcription that
had been inhibited by SOCS-1. This e¡ect appeared to be
speci¢c to SOCS-1 since the same experiments conducted
with SOCS-3 and increasing concentrations of transfected
SOCS-2 plasmid did not show any reactivation of the tran-
scriptional activity that had been inhibited by SOCS-3.
3.3. Activation of Jak2 kinase upon constitutive expression of
SOCS genes
Immunoblot analysis of 293 cell lysates that were immuno-
precipitated with Jak2 antibody revealed that, upon constitu-
tive expression of SOCS-1 or SOCS-3, tyrosine phosphoryla-
tion of Jak2 was abolished (Fig. 5). On the other hand, Jak2
tyrosine activity was not a¡ected by the constitutive expres-
sion of SOCS-2- or CIS-encoding plasmids.
4. Discussion
Key events in GH signal transduction are well de¢ned and
involve mainly the activation of the Jak2-STAT5 pathway.
The mechanisms by which signaling is switched o¡ are just
beginning to be understood with the recent identi¢cation of a
family of cytokine-inducible inhibitors of signaling [5^13].
Among them, SOCS-1 and SOCS-3 have been shown to block
GH-induced transactivation of a GH-responsive gene pro-
moter [15] ; we now assess the implication of SOCS-2 in GH
signaling.
The inhibitory e¡ect of SOCS-2 on GH signaling has not
been reported previously and was observed in the present
study only at low concentrations of transfected cDNA, stress-
ing the importance of using a large spectrum of concentra-
tions to study the e¡ect of SOCS molecules. In fact, only one
high concentration of transfected SOCS-2 has been used pre-
viously [15], impeding the characterization of this e¡ect. In
view of the general mechanism of action of this family of
proteins, this inhibitory e¡ect is not surprising but it repre-
sents to our knowledge the ¢rst demonstration of a role of
SOCS-2 in attenuating signaling of a member of the cytokine
receptor superfamily. Indeed, similar results have been ob-
tained recently with the closely related PRL receptor (Pezet
et al., submitted); whether this applies to other cytokines
needs to be evaluated by using similar dose-response experi-
ments. The inhibitory e¡ects of SOCS-1 and SOCS-3 are sim-
ilar to those observed previously on GH as well as on signal-
ing of several cytokines [14^18]. Moreover, SOCS-1 and -3 are
shown to be very potent inhibitors even when their expression
levels are comparable to endogenous ones, a situation which
also occurs in IL-6 signaling [17]. Although SOCS-3 has been
shown to be a weaker inhibitor than SOCS-1 against the
signaling of several cytokines [5,12,17], this does not appear
to be the case for GH-mediated activation of gene transcrip-
tion. Constitutive expression of these two inhibitors resulted
also in a dramatic reduction of Jak2 tyrosine kinase activity,
con¢rming the mechanism of action of these inhibitors as
described for other cytokines [11].
Another feature associated with SOCS-2 resided in its ca-
pacity to restore, in a dose-dependent manner, the GH recep-
tor functional activity that had been inhibited by SOCS-1.
Indeed, this e¡ect appeared to be speci¢c for the interaction
between SOCS-1 and -2 since it was not observed between
Fig. 4. E¡ect of constitutive co-expression of SOCS-1 and SOCS-2
or SOCS-3 and SOCS-2 on GH-induced transactivation of LHRE-
TK promoter. 293 cells were transfected and assayed as described in
Fig. 1. Di¡erent ratios (0:0 to 1:10) of SOCS-1 or SOCS-3 to
SOCS-2 cDNA were used for transfection studies. A ratio of 1:1 of
mkGHR to SOCS-1 or to SOCS-3 was used (50 ng of each plas-
mid) since this ratio was shown in Figs. 1 and 2 to result in a com-
plete inhibition of GH-induced transactivation of the LHRE pro-
moter. The dose-response curves are expressed in percentage of
control activity (in the absence of SOCS). Values are the means
þ S.E.M. of four independent experiments.
Fig. 5. Inhibition of tyrosine phosphorylation of Jak2 by SOCS-1
and SOCS-3. 293 cells expressing mkGHR (+), Jak2 and various
SOCS constructs (+) were lysed and immunoprecipitated with anti-
Jak2 antibody. Immunoprecipitated proteins were Western blotted
with anti-phosphotyrosine antibody (A) or anti-Jak2 antibody (B).
The position of Jak2 (130 kDa) is indicated on the left. Molecular
masses of protein standards are indicated on the right in kDa.
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SOCS-3 and -2 suggesting that the mechanisms of inhibition
of SOCS-1 and -3 are di¡erent, in agreement with a recent
report on leukemia inhibitory factor (LIF) and IL-6 signal
transduction [14]. The capacity of SOCS-2, when expressed
alone and at high concentrations, to restore and even to result
in a superinduction of reporter gene activity supports the
hypothesis that it can inhibit endogenous SOCS as illustrated
for SOCS-1. The present results thus demonstrate that SOCS-
2 has a dual e¡ect by acting as an inhibitor of GH signaling
but also by restoring signaling through inhibition of other
SOCS molecules. Given the pattern of sequential expression
of the genes encoding the SOCS molecules following GH ad-
ministration [15], SOCS-1 and -3 being expressed early and
SOCS-2 expressed later, it is tempting to speculate that, in
addition to its inhibitory e¡ect, a major function of SOCS-2
would be to restore late the sensitivity of cells to GH action
by inhibition of endogenous SOCS following their initial in-
hibitory e¡ects. Generation of mice lacking one or more genes
for SOCS [23] will be necessary to study in detail the role and
the functions of SOCS molecules in vivo and their implication
in GH signaling.
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